Predictive Markers in Breast and Other Cancers: A Review
Open Access
- 1 March 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 51 (3) , 494-503
- https://doi.org/10.1373/clinchem.2004.046227
Abstract
Background: Unpredictable efficacy and toxicity are hallmarks of most anticancer therapies. Predictive markers are factors that are associated with response or resistance to a particular therapy.Keywords
This publication has 75 references indexed in Scilit:
- The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application.Endocrine-Related Cancer, 2003
- Nuclear Receptor Minireview SeriesJournal of Biological Chemistry, 2001
- New prognostic factors for breast cancer recurrenceSeminars in Oncology, 2001
- Progesterone receptors in reproduction: functional impact of the A and B isoformsSteroids, 2000
- Randomized Intergroup Trial of Cisplatin-Paclitaxel Versus Cisplatin-Cyclophosphamide in Women With Advanced Epithelial Ovarian Cancer: Three-Year ResultsJNCI Journal of the National Cancer Institute, 2000
- Treatment of Breast CancerNew England Journal of Medicine, 1998
- A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinomaCancer, 1997
- The Biochemistry of MetastasisPublished by Elsevier ,1996
- The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells.Molecular and Cellular Biology, 1994
- Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function.Molecular Endocrinology, 1993